SLC25A34 | Solute carrier family 25, member 34 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC25A42 | Solute carrier family 25, member 42 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC25A46 | Solute carrier family 25, member 46 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC26A11 | Solute carrier family 26 (anion exchanger), member 11 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC26A2 | Solute carrier family 26 (anion exchanger), member 2 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC28A2 | Solute carrier family 28 (concentrative nucleoside transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC29A1 | Solute carrier family 29 (equilibrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC29A4 | Solute carrier family 29 (equilibrative nucleoside transporter), member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A10 | Solute carrier family 2 (facilitated glucose transporter), member 10 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
SLC2A14 | Solute carrier family 2 (facilitated glucose transporter), member 14 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC2A2 | Solute carrier family 2 (facilitated glucose transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC2A3 | Solute carrier family 2 (facilitated glucose transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A4 | Solute carrier family 2 (facilitated glucose transporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC30A1 | Solute carrier family 30 (zinc transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC30A5 | Solute carrier family 30 (zinc transporter), member 5 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC30A6 | Solute carrier family 30 (zinc transporter), member 6 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC30A7 | Solute carrier family 30 (zinc transporter), member 7 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
SLC32A1 | Solute carrier family 32 (GABA vesicular transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC34A2 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 2 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC34A3 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC35A2 | Solute carrier family 35 (UDP-galactose transporter), member A2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35C1 | Solute carrier family 35 (GDP-fucose transporter), member C1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35C2 | Solute carrier family 35 (GDP-fucose transporter), member C2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35E1 | Solute carrier family 35, member E1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC35F1 | Solute carrier family 35, member F1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC36A2 | Solute carrier family 36 (proton/amino acid symporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC37A1 | Solute carrier family 37 (glucose-6-phosphate transporter), member 1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC37A3 | Solute carrier family 37, member 3 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC38A10 | Solute carrier family 38, member 10 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC38A7 | Solute carrier family 38, member 7 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC39A7 | Solute carrier family 39 (zinc transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC43A1 | Solute carrier family 43 (amino acid system L transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC44A1 | Solute carrier family 44 (choline transporter), member 1 | CD markers Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC44A4 | Solute carrier family 44, member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
SLC45A3 | Solute carrier family 45, member 3 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC46A1 | Solute carrier family 46 (folate transporter), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC4A1 | Solute carrier family 4 (anion exchanger), member 1 (Diego blood group) | Blood group antigen proteins CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC4A10 | Solute carrier family 4, sodium bicarbonate transporter, member 10 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC4A2 | Solute carrier family 4 (anion exchanger), member 2 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC4A4 | Solute carrier family 4 (sodium bicarbonate cotransporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC4A7 | Solute carrier family 4, sodium bicarbonate cotransporter, member 7 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC50A1 | Solute carrier family 50 (sugar efflux transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC51B | Solute carrier family 51, beta subunit | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC5A1 | Solute carrier family 5 (sodium/glucose cotransporter), member 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A12 | Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A2 | Solute carrier family 5 (sodium/glucose cotransporter), member 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC5A5 | Solute carrier family 5 (sodium/iodide cotransporter), member 5 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC6A1 | Solute carrier family 6 (neurotransmitter transporter), member 1 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |